Top Message
Canon Medical Diagnostics Corporation was established in 1981 as an IVD manufacturer and a subsidiary of Kyowa Hakko Kogyo K.K. (current Kyowa Kirin Co., Ltd.). Ever since our establishment, we have pursued our mission of providing new values in the fields of biochemistry/immunology/medical devices and achieved the world's first invention of direct lipid measurement technology for enzyme method. We are grateful to all our stakeholders, not limited to our customers, but our partners along the way to become unique solutionproviders in the market.
We have seen a trend where many countries, including Japan, are heading toward aging society facing the issue of higher medical costs and diversifying medical needs. In this situation, the phrases such as precision medicine, evidenced-based medicine and personalized medicine have become significantly important for the better clinical outcome in our society. Our commitment is to leverage innovative technologies in R&D to provide highly advanced IVD solutions to such demands.
In July 2023, we joined the Canon Group and have taken a role of creating additional values in Canon’s medical division. On February 1, 2025, we changed our company name to “Canon Medical Diagnostics Corporation” strengthening and driving synergy for wider range of medical solutions from our core competence.
Quality is the highest priority in our operation, and all provisions of safety are closely monitored under ISO 13485.
As a part of Canon group, our aim is to carry out our IVD business in continuous growth and to make further contributions to healthcare practice.
President
Kamon Matsuzawa
Our Mission
We are committed to addressing people's health with sincerity, delivering new value to clinical diagnostics, and continuing to grow while fulfilling our social responsibilities.
Our Vision
By strengthening and expanding our unique areas of expertise, we aim to establish our position as a global company and develop diagnostic technologies and products that support "prevention, diagnosis, and treatment" to realize personalized healthcare.
Company Profile
| Name | Canon Medical Diagnostics Corporation |
|---|---|
| Head Office | Harumi Triton Square X-4F, 1-8-10 Harumi, Chuo-ku, Tokyo 104-6004, Japan |
| Date Established | April 1, 1981 |
| Paid-in Capital | 450 million yen |
| Representative | Kamon Matsuzawa, President |
History
| 1981 | Kyowa Medex Co., Ltd. established as a solely owned subsidiary of Kyowa Hakko Kogyo focusing on developing, manufacturing, and marketing in vitro diagnostics |
|---|---|
| 1990 | Fuji Plant, the new plant and research laboratories in Shizuoka Prefecture completed |
| 1994 | “Determiner HDL-C" for the direct measurement of HDL-Cholesterol launched |
| 1995 | "Determiner HbA1c" immuno particle assay-based diabetes test reagent launched |
| 1996 | "Determiner L HDL-C", commencement of export to worldwide on receipt of the world's first approval from the Centers for Disease Control and Prevention (CDC) |
| 1997 | "HM-JACK", a fully automated immunoassay analyzer system launched |
| 1998 | "Determiner L LDL-C" launched "DM-JACK" an automated analyzer for diabetes mellitus tests launched |
| 2001 | Fuji Plant ISO14001 certified |
| 2003 | Fuji Plant ISO13485 certified |
| 2006 | "MetaboLead RemL-C", the remnant lipoprotein cholesterol marker launched |
| 2008 | Kyowa Hakko Kirin Co., Ltd. established under capital and strategic alliance of Kyowa Hakko Kogyo and
Kirin Pharma. "MetaboLead HDL-C" launched |
| 2010 | "HM-JACKarc", a fully automated immunoassay analyzer system launched |
| 2013 | "MetaboLead HbA1c" launched |
| 2018 | Kyowa Medex joined Hitachi Chemical Group |
| 2019 | Kyowa Medex changed its name to Hitachi Chemical Diagnostics Systems Co., Ltd. "HM-JACKarcⅡ", a fully automated immunoassay analyzer system launched |
| 2021 | Hitachi Chemical Diagnostics Systems Co., Ltd. changed its name to Minaris Medical Co., Ltd. |
| 2022 | Fecal occult blood test reagents have obtained the EU's IVDR certification |
| 2023 | Minaris Medical Co., Ltd. joined Canon Medical Systems Group |
| 2024 | "HM-CODIAM", a fully automated immunoassay analyzer system launched |
| 2025 | Minaris Medical Co., Ltd. changed its name to Canon Medical Diagnostics Corporation |
Office Locations
Head Office
Harumi Triton Square X-4F, 1-8-10 Harumi, Chuo-ku,Tokyo
104-6004, Japan
Tel : +81-3-6219-7605
Fax : +81-3-6219-7614
Fuji Plant
600-1, Minami-ishiki, Nagaizumi-cho, Sunto-gun, Shizuoka-ken
411-0932, Japan
Tel : +81-55-988-6000
Fax : +81-55-988-6005
Associated Company
Canon Medical Diagnostics USA, Inc.
Business: Manufacturer of allergy in vitro diagnostics (IVD) reagents and instruments
630 Clyde Court, Mountain View, CA 94043, U.S.A.
Phone: +1-650-961-5501
Fax: +1-650-969-2745
Website: https://mdu.medical.canon